Table 1 Baseline demographic and clinical characteristics
Characteristic | Total Missing data, No. (%) | Participants (N = 137) | |
|---|---|---|---|
HBCAA group (N = 70) | Control group (N = 67) | ||
Sex, n (%) | |||
Male | 0 | 46 (65.7%) | 50 (74.6%) |
Female | 24 (34.3%) | 17 (25.4%) | |
Age, y | 0 | 70.3 (3.9) | 70.6 (4.5) |
Height, cm | 0 | 166 (8.7) | 165 (6.8) |
Weight, kg | 0 | 62.7 (10.3) | 63.2 (10.2) |
BMI, kg/m2 | 0 | 22.6 (2.9) | 23.2 (2.7) |
NRS-2002 score, n% | |||
2 | 0 | 11 (15.7%) | 15 (22.4%) |
3 | 0 | 24 (34.3%) | 27 (40.3%) |
4 | 0 | 21 (30%) | 12 (17.9%) |
≥ 5 | 0 | 14 (20%) | 13 (19.4%) |
TNM stage, n% | 0 | ||
I | 0 | 18 (25.7%) | 24 (35.8%) |
II | 21 (30.0%) | 21 (31.3%) | |
III | 31 (44.3%) | 22 (32.8%) | |
Surgery, n (%) | |||
Total gastrectomy | 0 | 38 (54.3%) | 35 (52.2%) |
Proximal gastrectomy | 4 (5.7%) | 3 (4.5%) | |
Distal gastrectomy | 28 (40.0%) | 29 (43.3%) | |
Baseline values at randomization | |||
Glucose, mmol/L | 4 (2.9) | 5.64 (1.14) | 5.30 (0.971) |
Total bilirubin, μmol/L | 0 | 11.5 (5.51) | 11.0 (4.88) |
Albumin, g/L | 0 | 41.5 (3.72) | 41.4 (3.48) |
FFA, mmol/L | 0 | 0.734 (0.311) | 0.715 (0.358) |
ALT, U/L | 0 | 16.0 (8.84) | 16.9 (14.8) |
AST, U/L | 0 | 48.5 (35.4) | 43.6 (18.9) |
BUN, mmol/L | 0 | 5.96 (1.53) | 5.67 (1.19) |
Serum creatinine, mol/L | 0 | 80.5 (15.9) | 82.4 (15.8) |
CD4 + /CD8 + ratio | 20 (14.6) | 2.04 (1.08) | 1.91 (1.01) |
IL-6, pg/mL | 0 | 3.81 (2.87) | 3.90 (3.22) |